ArticleExperimental hematology & oncology2025

IL-6-mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL-6 receptor-alpha and activation of STAT3/NRF2 pathway.

Amani Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.